Transcription of Nucleic Acid Pathogen Testing - Cigna
{{id}} {{{paragraph}}}
Medical Coverage Policy Effective Date .. 9/15/2021. Next Review 1/15/2022. Coverage Policy Number .. 0530. Nucleic acid Pathogen Testing Table of Contents Related Coverage Resources Overview .. 1 Preventive Care Services Coverage General Background ..3. Medicare Coverage Determinations ..8. Coding/Billing Information ..9. References ..36. INSTRUCTIONS FOR USE. The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients.
diagnosis of onychomycosis or nail dystrophy has not been established. Chlamydia (Chlamydia Trachomatis) Chlamydial infection is the most frequently reported infectious disease in the United States (IDSA, 2018; CDC, ... tubal factor infertility, ectopic pregnancy, and chronic pelvic pain. Sexually acquired
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}